Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about AbbVie Inc

Recent news which mentions AbbVie Inc

< Previous 1 2 Next >
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags Health & Science Business Biotechnology
From CNBC.com News
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan
Tags Pharmaceuticals Biotech and Pharmaceuticals Johnson & Johnson
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags Johnson & Johnson Breaking News: Business Business News
From CNBC.com News
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
Tags General Mills Inc Stock markets Business
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags AstraZeneca PLC Biotechnology Business
From CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
Tags Health care industry Breaking News: Politics Politics
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags LILLY DRN Abbvie Inc Biotechnology
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Roche Holding AG Biotech and Pharmaceuticals Johnson & Johnson
From CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags GE Vernova Inc Stock Picks Chipotle Mexican Grill Inc
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Johnson & Johnson Business News Breaking News: Business
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Gilead Sciences Inc Amgen Inc Merck & Co Inc
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags CNBC Sport Sports TV Marketing and advertising
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Healthy Returns AstraZeneca PLC Health care industry
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Stock markets Market Outlook Business
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Biotechnology Business Novo Nordisk A/S
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Investment strategy KB Home Amgen Inc
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Mad Money Markets Oracle Corp
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags stocks Arch Capital Group Ltd Meta Platforms Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags US: News Eli Lilly and Co Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Johnson & Johnson Healthy Returns Breaking News: Politics
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Biotech and Pharmaceuticals UnitedHealth Group Inc Health care industry
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Companies Breaking news Abbott Laboratories
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Space industry Breaking News: Technology Technology
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Mad Money Investment strategy Markets
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Health care industry Alvotech SA Daiichi Sankyo Co Ltd
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Johnson & Johnson Business News Biotech and Pharmaceuticals
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Roche Holding AG Business News ImmunoGen Inc
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags BioNTech SE Business News Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Economy Walmart Inc JPMORGAN DRN
From CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Tags Pharmaceuticals Biotech and Pharmaceuticals Health care industry
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.